Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical use of carnitine. Past, present and future.

Literature DB >> 2103685

Clinical use of carnitine. Past, present and future.

N Siliprandi¹, F Di Lisa, R Menabó.

Abstract

Entities: Chemical

Mesh：

Substances：
Carnitine

Year: 1990 PMID： 2103685 DOI： 10.1007/978-1-4684-5826-8_11

Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors: Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal: Pediatr Nephrol Date: 2005-12-23 Impact factor: 3.714

2. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.

Authors: Bilal Aoun; Etienne Bérard; Renata Vitkevic; Axelle Dehée; Albert Bensman; Tim Ulinski
Journal: Pediatr Nephrol Date: 2009-08-07 Impact factor: 3.714

3. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia.

Authors: Xuan Wang; Meihong Xiu; Keqiang Wang; Xiuru Su; Xirong Li; Fengchun Wu
Journal: Metabolomics Date: 2022-07-11 Impact factor: 4.747

4. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.

Authors: Celalettin Koşan; Lale Sever; Nil Arisoy; Salim Calişkan; Ozgür Kasapçopur
Journal: Pediatr Nephrol Date: 2003-10-02 Impact factor: 3.714

5. A Dose-Dependent Effect of Carnipure^® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model.

Authors: Kazim Sahin; Cemal Orhan; Osman Kucuk; Nurhan Sahin; Mehmet Tuzcu; Besir Er; Shane Durkee; Aouatef Bellamine
Journal: Nutrients Date: 2020-05-23 Impact factor: 5.717

Clinical use of carnitine. Past, present and future.

Review 1. The use of levo-carnitine in children with renal disease: a review and a call for future studies.

2. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.

3. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia.

4. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.

5. A Dose-Dependent Effect of Carnipure^® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model.

6. Circulating Carnitine Levels and Breast Cancer: A Matched Retrospective Case-Control Study.

7. Modulation of cytokine production by carnitine.

Review 8. Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?

Clinical use of carnitine. Past, present and future.

Review 1. The use of levo-carnitine in children with renal disease: a review and a call for future studies.

2. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.

3. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia.

4. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients.

5. A Dose-Dependent Effect of Carnipure® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model.

6. Circulating Carnitine Levels and Breast Cancer: A Matched Retrospective Case-Control Study.

7. Modulation of cytokine production by carnitine.

Review 8. Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?

5. A Dose-Dependent Effect of Carnipure^® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model.